Bioactive Food Ingredients in Managing Inflammatory Diseases
暫譯: 生物活性食品成分在炎症疾病管理中的應用

Ansari, MD Meraj, Akhtar, Nadeem

  • 出版商: Springer
  • 出版日期: 2026-07-06
  • 售價: $9,150
  • 貴賓價: 9.5$8,692
  • 語言: 英文
  • 頁數: 382
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3032238137
  • ISBN-13: 9783032238139
  • 海外代購書籍(需單獨結帳)

商品描述

Inflammatory and non-communicable diseases (NCDs) have a significant impact on public health as well as socio-economic conditions across the globe. According to the WHO (World Health Organization), NCDs kill a devastating 41 million humans every year. Sufficient nutrition and good health depend on eating a balanced diet. It guards against a variety of chronic NCDs, including cancer, diabetes and heart disease. A balanced diet must include a range of foods. Advances in science, technology, and the interpretation of food chemistry and biological functions by food researchers have led to a shift in consumers' perceptions of food functions, from satisfaction and nutrition to health. Long-term unhealthy diets cause many human chronic diseases, as epidemiological research demonstrates. Many bioactive food components, such as polyphenols, polysaccharides, flavonoids, peptides and saponins, offer multiple health benefits. Research also demonstrates that food plays a significant role in the majority of acute and chronic human diseases. In order to prevent chronic diseases, improve quality of life, and eventually develop new or enhanced healthy meals, it is crucial to have a deeper understanding of the bioaccessibility, safety concerns and underlying health-promoting mechanisms of food-derived bioactive components. Despite tremendous advancements in therapeutics, the cure of dreadful diseases such as cancer, neurodegenerative disease, colitis and rheumatoid arthritis is still a significant challenge. Furthermore, therapeutic repercussions in terms of side effects and the emergence of multi-drug resistance make therapeutics more complicated.

Bioactive Food Ingredients in Managing Inflammatory Diseases illustrates the significance of bioactive food ingredients in tackling inflammation and inflammatory diseases. The potential of food ingredients as anti-oxidative and anti-inflammatory strategies, their mechanistic insight into scavenging free radicals, and their application in managing inflammation and inflammatory diseases. With the focus on challenges and advances in using bioactive food ingredients for enhanced therapeutic efficacy. The text studies the potentiality of bioactive food ingredients in the management of inflammation and inflammatory disease, providing researchers with a valuable single source reference for the very latest in bioactive foods and their use in treating inflammatory diseases.

商品描述(中文翻譯)

炎症性疾病和非傳染性疾病(NCDs)對全球公共健康及社會經濟狀況有著重大影響。根據世界衛生組織(WHO)的資料,非傳染性疾病每年造成4100萬人喪生。充足的營養和良好的健康依賴於均衡的飲食。均衡飲食能防範多種慢性非傳染性疾病,包括癌症、糖尿病和心臟病。均衡飲食必須包含多樣的食物。科學、技術的進步以及食品研究者對食品化學和生物功能的詮釋,已使消費者對食品功能的認知從滿足感和營養轉變為健康。流行病學研究顯示,長期不健康的飲食會導致許多人類慢性疾病。許多生物活性食品成分,如多酚、寡糖、類黃酮、肽和皂苷,提供多重健康益處。研究還表明,食品在大多數急性和慢性人類疾病中扮演著重要角色。為了預防慢性疾病、改善生活品質,並最終開發新的或增強的健康餐飲,深入了解食品來源的生物活性成分的生物可及性、安全性問題及其促進健康的機制至關重要。儘管治療技術取得了巨大的進展,但治療癌症、神經退行性疾病、結腸炎和類風濕性關節炎等可怕疾病仍然是一項重大挑戰。此外,治療的副作用及多重藥物抗藥性的出現使得治療變得更加複雜。

《管理炎症性疾病的生物活性食品成分》闡述了生物活性食品成分在應對炎症和炎症性疾病中的重要性。食品成分作為抗氧化和抗炎策略的潛力、其清除自由基的機制洞察,以及在管理炎症和炎症性疾病中的應用。該文本專注於使用生物活性食品成分以增強治療效果的挑戰和進展。研究生物活性食品成分在炎症和炎症性疾病管理中的潛力,為研究人員提供了最新的生物活性食品及其在治療炎症性疾病中的應用的寶貴單一參考來源。

作者簡介

Dr. Md. Meraj Ansari is a Research Professor at the Department of Animal Biotechnology, Jeju National University, Jeju City, Republic of Korea. He has completed his Ph.D. in Toxicology from Jamia Hamdard, New Delhi, India, studying the therapeutic effect of natural compounds and the functionality of heavy metals and trace elements in the pathogenesis of rheumatoid arthritis. Subsequently, he had worked as a post-doctoral researcher at the Institute of Nano Science and Technology, Mohali, Punjab, India. He continued his work on nanoformulations of natural compounds and synthetic drugs to block TNF and IL-6 signaling in rheumatoid arthritis and Ulcerative Colitis. Dr Ansari was awarded a Young scientist award in 2019 by Department of Health Research, Ministry of Health and Family welfare, government of India. He had worked as a Young Scientist at the Centre of Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali, Punjab, India. His main focus was nanoformulations and drug delivery in cancer therapeutics. His scientific contribution includes more than 24 articles in peer-reviewed international journals and 8 book chapters. He reviewed several research articles for reputed journals, including Environmental toxicology, Frontiers in pharmacology, Frontiers in nutrition immunology, Frontiers in Oncology, Toxicology mechanism and method, cancer control and many more.

Dr. Nadeem Akhtar, a scientist, is currently making significant strides in the animal health and longevity sector for a leading Canadian company, CBS Bio Platforms Inc. His impressive background demonstrates that he has held a variety of important positions in academia and research throughout his career.

Dr. Akhtar was a Research Associate at the University of Guelph, Canada, where the objective of his work was to improve companion animal's health in order to promote a superior and more health-conscious lifestyle. Prior to assuming this position, he excelled as a postdoctoral researcher at the Department of Chemical Engineering, University of Waterloo, Canada (2019-2021) and the Department of Animal Biosciences, University of Guelph, Canada (2015-2019).

His accomplishments in the National Eligibility Test (NET-2010) and Graduate Aptitude Test (GATE) in Life Sciences (2010) and Biotechnology (2011) further emphasize his academic excellence. He earned his Ph.D. from the esteemed Department of Biotechnology at the Thapar Institute of Engineering and Technology in India.

Dr. Akhtar's scientific contributions are nothing short of remarkable, with over 28 articles published in peer-reviewed international journals as well as 12 book chapters and four edited books. His abilities extend to patent accomplishments, as he has one granted patent to his name. In addition to his research, he has shown his dedication to knowledge advancement by serving as a reviewer for prestigious journals such as RSC Advances, the Journal of Applied Microbiology, Scientific Reports, and Poultry Science.

Dr. Akhtar's career exemplifies dedication and excellence, demonstrating his invaluable contributions to the fields of animal science and biotechnology. His journey continues to motivate and shape the global scientific landscape.

作者簡介(中文翻譯)

Dr. Md. Meraj Ansari 是韓國濟州特別自治道濟州國立大學動物生物技術系的研究教授。他在印度新德里的 Jamia Hamdard 完成了毒理學博士學位,研究天然化合物的治療效果以及重金屬和微量元素在類風濕性關節炎發病機制中的功能。隨後,他在印度旁遮普省莫哈利的納米科學與技術研究所擔任博士後研究員。他繼續研究天然化合物和合成藥物的納米配方,以阻斷類風濕性關節炎和潰瘍性結腸炎中的 TNF 和 IL-6 信號傳導。Ansari 博士於 2019 年獲得印度衛生與家庭福利部健康研究部的青年科學家獎。他曾在印度旁遮普省莫哈利的國立藥學教育與研究所藥劑學系擔任青年科學家,主要專注於癌症治療中的納米配方和藥物傳遞。他的科學貢獻包括在同行評審的國際期刊上發表超過 24 篇文章和 8 章書籍。他為多個知名期刊審稿,包括環境毒理學、藥理學前沿、營養免疫學前沿、腫瘤學前沿、毒理學機制與方法、癌症控制等。

Dr. Nadeem Akhtar 是一位科學家,目前在加拿大一家領先的公司 CBS Bio Platforms Inc. 在動物健康和長壽領域取得了顯著進展。他的卓越背景顯示他在學術界和研究領域擔任過多個重要職位。

Akhtar 博士曾是加拿大圭爾夫大學的研究助理,他的工作目標是改善伴侶動物的健康,以促進更優越和更健康的生活方式。在擔任此職位之前,他在加拿大滑鐵盧大學化學工程系(2019-2021)和圭爾夫大學動物生物科學系(2015-2019)擔任博士後研究員,表現優異。

他在國家資格考試(NET-2010)和生命科學(2010)及生物技術(2011)的研究生入學考試(GATE)中的成就進一步強調了他的學術卓越。他在印度 Thapar 工程技術學院的生物技術系獲得博士學位。

Akhtar 博士的科學貢獻相當卓越,已在同行評審的國際期刊上發表超過 28 篇文章,以及 12 章書籍和四本編輯書籍。他的能力還延伸至專利成就,擁有一項已授予的專利。除了研究外,他還通過擔任 RSC Advances、應用微生物學期刊、科學報告和家禽科學等知名期刊的審稿人,展現了他對知識進步的奉獻。

Akhtar 博士的職業生涯體現了奉獻和卓越,展示了他對動物科學和生物技術領域的寶貴貢獻。他的旅程繼續激勵並塑造全球科學界的面貌。

最後瀏覽商品 (1)